文献速递生殖医学

KCNU1双等位基因变异导致顶体反应受损和男性不育

Bi-allelic variants in KCNU1 cause impaired acrosome reactions and male infertility.
PubMed 文献 · Hum Reprod · 2022-01-01

研究纳入126例典型弱精症或受精失败的男性不育个体,对两个近亲家系中的2例不育男性行全外显子组测序和纯合子定位,发现KCNU1纯合错义变异c.2144A>G(p.His715Arg)和纯合供体剪接位点变异c.1295+3A>C(p.Val405Glyfs*8)。功能实验和敲入小鼠模型证实这些变异导致KCNU1功能丧失、顶体反应受损和男性不育,卵胞浆内单精子注射可挽救该缺陷。

要点

  • KCNU1双等位基因变异是男性不育的新遗传病因,主要表现为精子顶体反应受损。
  • 两个近亲家系中发现的KCNU1纯合变异导致蛋白水平降低和功能丧失。
  • 卵胞浆内单精子注射可挽救KCNU1缺陷所致的不育。

核心结论

  • KCNU1双等位基因变异是男性不育的新致病基因,主要因精子顶体反应受损所致。
  • 本研究首次建立KCNU1缺陷与男性不育之间的因果关系,证实KCNU1在人类生殖中的关键作用。
  • 研究结果扩展了对人类精子顶体反应关键基因的认识,并提供新的不育遗传标记。

研究设计与样本

  • 研究纳入126例典型弱精症或受精失败的男性不育个体,重点分析来自两个近亲家系的2例不育男性(2015年至2020年)。
  • 采用全外显子组测序和纯合子定位筛选KCNU1变异,Sanger测序确认。
  • 2020年9月构建C57BL/6N小鼠敲入模型,进行体内功能研究及治疗策略探索。
  • 功能实验包括蛋白质印迹、顶体反应检测和免疫荧光染色,并开展IVF和ICSI探索治疗策略。
  • 不育个体招募自上海交通大学附属上海第九人民医院。

主要发现

  • 在2例不育男性中鉴定出KCNU1纯合错义变异c.2144A>G(p.His715Arg)和纯合供体剪接位点变异c.1295+3A>C(p.Val405Glyfs*8)。
  • 剪接位点变异影响KCNU1正常可变剪接,导致KCNU1功能丧失。
  • 错义致病变异降低患者精子和敲入小鼠模型精子中KCNU1蛋白水平,导致顶体反应受损和男性不育。
  • 卵胞浆内单精子注射能够挽救该缺陷。

关键数值与推荐

  • KCNU1纯合错义变异为c.2144A>G(p.His715Arg)。
  • KCNU1纯合供体剪接位点变异为c.1295+3A>C(p.Val405Glyfs*8)。
  • 卵胞浆内单精子注射可挽救KCNU1缺陷所致不育。

临床怎么用

  • 作者报告卵胞浆内单精子注射能够挽救KCNU1缺陷所致的不育。

局限性

  • KCNU1的确切分子机制和通路需在未来进一步探索。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are there new genetic factors responsible for male infertility with normal sperm quantity and morphology? SUMMARY ANSWER: We identified the bi-allelic variants in KCNU1 and confirmed it a novel pathogenetic gene for male infertility mainly due to impaired sperm acrosome reactions (ARs). WHAT IS KNOWN ALREADY: Until now, the underlying genetic determinants for male affected individuals exhibiting normal sperm quantity and morphology have been largely unknown. Potassium/calcium-activated channel subfamily U member 1 (KCNU1) is a sperm-specific potassium channel. The Kcnu1 null mutation in male mice causes infertility due to the impaired progressive motility and AR. STUDY DESIGN, SIZE, DURATION: We recruited a cohort of 126 male infertility individuals with typical asthenospermia or fertilization failure and focused on two infertile males from two consanguineous families from 2015 to 2020; whole-exome sequencing and homozygosity mapping were performed. We identified a homozygous missense variant (c.2144A>G, p.His715Arg) and a homozygous donor splice-site variant (c.1295 + 3A>C, p.Val405Glyfs*8) in KCNU1. Then, we generated a knock-in (KI) mouse model in September 2020 and have now carried out functional studies and possible treatment strategies. PARTICIPANTS/MATERIALS, SETTING, METHODS: The affected individuals with infertility were recruited from the Shanghai Ninth Hospital affiliated to Shanghai Jiao Tong University. Genomic DNA from the affected individual was extracted from peripheral blood. Whole-exome sequencing, homozygosity mapping and in silico analyses were used to screen and identify KCNU1 variants, and the variants were confirmed by Sanger sequencing. We used C57BL/6N mouse to construct KI mouse model to mimic the reproductive phenotype in vivo. We performed functional experiments by western blotting, AR assay and immunofluorescent Staining. Finally, we performed IVF and ICSI to explore the treatment strategies. MAIN RESULTS AND THE ROLE OF CHANCE: We identified a homozygous missense variant (c.2144A>G, p.His715Arg) and a homozygous donor splice-site variant (c.1295 + 3A>C, p.Val405Glyfs*8) in KCNU1 in two infertile males. We demonstrated that the splice-site variant affected normal alternative splicing of KCNU1, thus leading to the loss of function of KCNU1. Meanwhile, the missense pathogenic variant reduced the KCNU1 protein levels in sperm of both the affected individual and the KI mouse model, resulting in impaired ARs and male infertility. Intracytoplasmic sperm injection was able to rescue the deficiencies. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The exact molecular mechanism of KCNU1 and pathways need to be further explore in the future. WIDER IMPLICATIONS OF THE FINDINGS: This is the first report that establishes a causal relationship between KCNU1 deficiency and male infertility, confirming the critical role of KCNU1 in human reproduction. Our findings expand our knowledge of the genes that play critical roles in the human sperm AR and provide a new genetic marker for infertility. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the SHIPM-pi fund no. JY201801 from the Shanghai Institute of Precision Medicine, Ninth People's Hospital Shanghai Jiao Tong University School of Medicine, the National Natural Science Foundation of China (81725006, 81771649, 81822019, 81771581, 81971450, 81971382, 82001538 and 82071642). The authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Liu R, Yan Z, Fan Y, et al. Bi-allelic variants in KCNU1 cause impaired acrosome reactions and male infertility. Hum Reprod. 2022. PMID: 35551387. doi:10.1093/humrep/deac102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。